Sign in
4

Changes in Ownership

AGIOS PHARMACEUTICALS, INC. Filed Acc 0001209191-17-022346

Chief Scientific Officer sold 6,438 shares at $55.00 ($354,090)

  • Chief Scientific Officer acquired 6,438 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Biller Scott Chief Scientific Officer 2017-03-20 Option exercise +5,933 $9.05 $53,694 21,403 D
Biller Scott Chief Scientific Officer 2017-03-20 Sale −5,933 $55.00 $326,315 15,470 D
Biller Scott Chief Scientific Officer 2017-03-20 Option exercise +505 $0.47 $236 15,975 D
Biller Scott Chief Scientific Officer 2017-03-20 Sale −505 $55.00 $27,775 15,470 D
Derivatives
Biller Scott Chief Scientific Officer 2017-03-20 Option exercise · Common stock (right to buy) −505 4,969 D
Biller Scott Chief Scientific Officer 2017-03-20 Option exercise · Common stock (right to buy) −5,933 48,157 D
Open-market sales · 6,438 sh · avg $55.00 · $354,090
Loading xslF345X03/doc4.xml…